Leadership & Pay ·
Atara Biotherapeutics, Inc. announced the departure of Chief Accounting Officer Yanina Grant-Huerta, effective July…
ATRAAtara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. announced the departure of Chief Accounting Officer Yanina Grant-Huerta, effective July 17, 2026, and the appointment of Kevin G. Sarney as interim chief financial officer, effective June 26, 206, as a consultant via Charles River CFO, Inc. Mr. Sarney will serve as the Company's principal financial officer and principal accounting officer. Atara Biotherapeutics, Inc. is a biotechnology company focused on cell therapy products.